Please login to the form below

Not currently logged in

Summit Therapeutics

This page shows the latest Summit Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Summit Therapeutics partners with Akeso in deal worth $5bn

Summit Therapeutics partners with Akeso in deal worth $5bn

Summit Therapeutics (Summit) has announced a definitive agreement of its partnership with Akeso in a deal worth up to $5bn to in-licence its breakthrough bispecific antibody, ivonescimab. ... Robert Duggan, chairman and chief executive officer of Summit,

Latest news

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Collected Group

Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...